Literature DB >> 11507369

Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis.

O W Hamer1, M Gnad, J Schölmerich, K D Palitzsch.   

Abstract

A 36-year-old patient with primary haemochromatosis presented with erectile dysfunction. Laboratory findings revealed reduced levels of luteinizing hormone (0.4 IU/l; normal range 2-12 IU/l), follicle-stimulating hormone (0.1 IU/l; normal range 1-12 IU/l) and testosterone (0.49 microg/l; normal range 2-8.1 microg/l). We made the diagnosis of secondary hypogonadism due to haemochromatosis, which is generally supposed to be irreversible. Due to consequent venesection therapy, levels of ferritin and transferrin saturation could be normalized, and levels of luteinizing hormone and follicle-stimulating hormone increased to normal ranges. Also, testosterone levels became normal and remained so without any androgen substitution. The patient subsequently regained erectile function and potency. This case underlines the fact that a hypogonadotrophic hypogonadism caused by iron overload can be reversed by a consequent venesection therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507369     DOI: 10.1097/00042737-200108000-00021

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly.

Authors:  J Scott Gabrielsen; Dolores J Lamb; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-06-01       Impact factor: 3.092

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

Review 3.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

Review 4.  All patients with 'idiopathic' hypopituitarism should be screened for hemochromatosis.

Authors:  Anthony S Lewis; C Hamish Courtney; A Brew Atkinson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

5.  Hypogonadotropic hypogonadism in men with hereditary hemochromatosis.

Authors:  Rabih El Osta; Nicolas Grandpre; Nicolas Monnin; Jacques Hubert; Isabelle Koscinski
Journal:  Basic Clin Androl       Date:  2017-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.